Elsevier

Vaccine

Volume 10, Issue 11, 1992, Pages 740-741
Vaccine

Short paper
Recombinant versus plasma-derived hepatitis B vaccine: comparison of immunogenicity in medical students

https://doi.org/10.1016/0264-410X(92)90507-GGet rights and content

Abstract

A group of 92 medical students were immunized with a commercial recombinant hepatitis B vaccine (Engerix B). Antibody responses were determined and compared with those to plasma-derived Pasteur vaccine, obatined in 1986. Antibody concentrations were significantly higher in the group given recombinant vaccine, therefore this vaccine has superior immunogenicity and probably confers extended duration of protection.

References (10)

There are more references available in the full text version of this article.

Cited by (17)

  • 1994, Vaccine
  • 24 year outcomes of hepatitis B vaccination in Hangzhou, China

    2015, Human Vaccines and Immunotherapeutics
View all citing articles on Scopus
View full text